- Report
- October 2024
- 183 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 194 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- April 2024
- 95 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 174 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 297 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 182 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- January 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- August 2024
- 147 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- January 2025
- 191 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- July 2024
- 100 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- November 2024
- 345 Pages
Global
From €3797EUR$4,000USD£3,203GBP
- Report
- December 2024
Global
From €7120EUR$7,500USD£6,006GBP
- Report
- October 2024
- 189 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- July 2024
- 156 Pages
Global
From €4035EUR$4,250USD£3,403GBP
- Report
- September 2024
- 35 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- May 2024
- 161 Pages
Global
From €3797EUR$4,000USD£3,203GBP
- Report
- December 2024
Global
From €7120EUR$7,500USD£6,006GBP
- Report
- August 2024
- 192 Pages
Global
From €3797EUR$4,000USD£3,203GBP
- Report
- August 2024
- 66 Pages
North America
From €5691EUR$5,995USD£4,801GBP

The Cardiac Valve market is a segment of the Cardiovascular Devices industry, which includes a range of products used to diagnose and treat heart conditions. Cardiac valves are used to regulate the flow of blood through the heart, and can be either mechanical or biological. Mechanical valves are typically made of metal and are designed to last for many years, while biological valves are made of animal tissue and are designed to be replaced over time. Both types of valves are used to treat a variety of heart conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation.
The Cardiac Valve market is highly competitive, with a number of companies offering a range of products. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Other companies in the market include CryoLife, Symetis, and Neovasc. Show Less Read more